Posts

Pioneering Sylvester physician elected to Society of Ne...

Macarena de la Fuente, MD, chief of neuro-oncology at Sylvester Comprehensive Ca...

Artificial intelligence enhances radiotherapy for Henry...

Patients undergoing radiation therapy for certain types of cancer at Henry Ford ...

New, promising clinical trial for glioblastoma starting...

UNC Health is now enrolling patients as part of a multicenter clinical trial for...

Deciphering reproductive aging in women using a NOD/SCI...

“The proposed NOD/SCID model, with its accelerated ovarian aging, holds particul...

The annual economic burden of urinary incontinence coul...

Brussels, 8 November 2023 – New international research on the economic burden of...

New compound shows early promise for treatment of Lou G...

In science, a simple but thorough observation can kick-start the most surprising...

Why a surprising discovery, warming seas and the demise...

Some unexpected shark strandings and subsequent surprises following autopsies ha...

Southern Alaska’s national forests key to meeting clima...

CORVALLIS, Ore. – Analyses of U.S. national forests led by Oregon State Universi...

TLM-005 by Therillume for Glioblastoma Multiforme (GBM)...

TLM-005 is under clinical development by Therillume and currently in Phase I for...

TLM-004 by Therillume for Glioblastoma Multiforme (GBM)...

TLM-004 is under clinical development by Therillume and currently in Phase I for...

TLM-003 by Therillume for Glioblastoma Multiforme (GBM)...

TLM-003 is under clinical development by Therillume and currently in Phase I for...

StromaForte by Swedish StromaBio for Cardiovascular Dis...

StromaForte is under clinical development by Swedish StromaBio and currently in ...

Fulvestrant by Kashiv BioSciences for Metastatic Breast...

Fulvestrant is under clinical development by Kashiv BioSciences and currently in...

TLM-101 by Therillume for Neurofibromatoses Type I (Von...

TLM-101 is under clinical development by Therillume and currently in Phase I for...

TLM-006 by Therillume for Glioblastoma Multiforme (GBM)...

TLM-006 is under clinical development by Therillume and currently in Phase I for...

AWT-020 by Anwita Biosciences for Lymphoma: Likelihood ...

AWT-020 is under clinical development by Anwita Biosciences and currently in Pha...